{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:46:45Z","timestamp":1763563605932},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1994,3,1]],"date-time":"1994-03-01T00:00:00Z","timestamp":762480000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporosis Int"],"published-print":{"date-parts":[[1994,3]]},"DOI":"10.1007\/bf01623227","type":"journal-article","created":{"date-parts":[[2005,4,30]],"date-time":"2005-04-30T21:17:09Z","timestamp":1114895829000},"page":"76-83","source":"Crossref","is-referenced-by-count":87,"title":["Two years' effectiveness of intravenous pamidronate (APD) versus oral fluoride for osteoporosis occurring in the postmenopause"],"prefix":"10.1007","volume":"4","author":[{"given":"D.","family":"Thi\u00e9baud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Burckhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Melchior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. F.","family":"Jacquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Schnyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gobelet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF02555897","volume":"49","author":"S Ljunghall","year":"1991","unstructured":"Ljunghall S, Gardsell P, Johnell O, Larsson K, Lindh E, Obrant K, Sernbo I. Synthetic human calcitonin in postmenopausal osteoporosis: a placebo-controlled, double-blind study. Calcif Tissue Int 1991;49:17\u20139.","journal-title":"Calcif Tissue Int"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2165\/00003495-199142060-00003","volume":"42","author":"H Fleisch","year":"1991","unstructured":"Fleisch H. Bisphosphonates: pharmacology and use in the treatment of tumor-induced hypercalcemia and metastatic bone disease. Drugs 1991;42:919\u201344.","journal-title":"Drugs"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7326\/0003-4819-102-3-319","volume":"102","author":"B Ettinger","year":"1985","unstructured":"Ettinger B, Genant HK, Cann CE, et al. Long term estrogen replacement therapy prevents bone loss and fracture. Ann Intern Med 1985;102:319\u201324.","journal-title":"Ann Intern Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM198711053171901","volume":"317","author":"DP Kiel","year":"1987","unstructured":"Kiel DP, Felson DT, Anderson JJ, et al. Hip fracture and the use of estrogens in postmenopausal women. N Engl J Med 1987;317:1169\u201374.","journal-title":"N Engl J Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"594","DOI":"10.7326\/0003-4819-113-8-594","volume":"113","author":"ANA Tosteson","year":"1990","unstructured":"Tosteson ANA, Rosenthal DI, Melton III LJ, Weinstein MC. Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy. Ann Intern Med 1990;113:594\u2013603.","journal-title":"Ann Intern Med"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1056\/NEJM199003223221203","volume":"322","author":"BI Riggs","year":"1990","unstructured":"Riggs BI, Hodgson SF, O'Fallow WM, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990;322:802\u20139.","journal-title":"N Engl J Med"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF01625446","volume":"1","author":"M Kleerekoper","year":"1991","unstructured":"Kleerekoper M, Peterson EL, Nelson DA, Philips E, Schork MA, Tilley BC, Parfitt AM. A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis. Osteoporosis Int 1991;1:155\u201361.","journal-title":"Osteoporosis Int"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(88)92834-6","volume":"2","author":"D Mamelle","year":"1988","unstructured":"Mamelle D, Dusan R, Martin JL, Prost A, Meunier PJ, Guillaume MM, et al. Risk-benefit ratio of sodium fluoride in primary vertebral osteoporosis. Lancet 1988;2:361\u20133.","journal-title":"Lancet"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0002-9343(88)80344-9","volume":"85","author":"D Thi\u00e9baud","year":"1988","unstructured":"Thi\u00e9baud D, Jaeger P, Gobelet C, Burckhardt P. A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone. Am J Med 1988;85:207\u201312.","journal-title":"Am J Med"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/jbmr.5650010610","volume":"1","author":"D Thi\u00e9baud","year":"1986","unstructured":"Thi\u00e9baud D, Jaeger P, Jacquet AF, Burckhardt P. A single-day treatment of tumor-induced hypercalcemia by intravenous amino-hydroxypropylidene bisphosphonate. J Bone Min Res 1986;1:555\u201362.","journal-title":"J Bone Min Res"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0169-6009(89)90097-4","volume":"5","author":"AB Hodsman","year":"1989","unstructured":"Hodsman AB. Effects of cyclical therapy for osteoporosis using an oral regimen of inorganic phosphate and sodium etidronate: a clinical and bone histomorphometric study. Bone Miner 1989;5:201\u201312.","journal-title":"Bone Miner"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM199005033221803","volume":"322","author":"T Storm","year":"1990","unstructured":"Storm T, Thamsborg G, Steiniche T, Genant HK, Soerensen OH. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 1990;322:1265\u201371.","journal-title":"N Engl J Med"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199007123230201","volume":"323","author":"NB Watts","year":"1990","unstructured":"Watts NB, Harris ST, Genant HK, et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 1990;323:73\u20139.","journal-title":"N Engl J Med"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF01625449","volume":"1","author":"PD Miller","year":"1991","unstructured":"Miller PD, Neal BJ, Mclntyre DO, Yanover MJ, Anger MS, Kowalski L. Effect of cyclical therapy with phosphorus and etidronate on axial bone mineral density in postmenopausal osteoporotic women. Osteoporosis Int 1991;1:171\u20136.","journal-title":"Osteoporosis Int"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(88)92721-3","volume":"1","author":"IR Reid","year":"1988","unstructured":"Reid IR, King AR, Alexander CJ, Ibbertson HK. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). Lancet 1988;1:143\u20136.","journal-title":"Lancet"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0169-6009(89)90095-0","volume":"5","author":"R Valkema","year":"1989","unstructured":"Valkema R, Vismans FJFE, Papapoulos SE, Pauwels EKJ, Bijvoet OLM. Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD. Bone Miner 1989;5:183\u201392.","journal-title":"Bone Miner"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01625440","volume":"1","author":"GA Fromm","year":"1991","unstructured":"Fromm GA, Vega E, Plantalech L, Galich AM, Mautalen CA. Differential action of pamidronate on trabecular and cortical bone in women with involutional osteoporosis. Osteoporosis Int 1991;1:129\u201333.","journal-title":"Osteoporosis Int"},{"issue":"Suppl 1","key":"CR18","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S8756-3282(09)80009-4","volume":"13","author":"SW Papapoulos","year":"1992","unstructured":"Papapoulos SW, Landman JO, Bijvoet OLM, L\u00f6wik CWGM, Valkema R, Pouwels EKJ, Vermeij P. The use of bisphosphonates in the treatment of osteoporosis. Bone 1992;13(Suppl 1):S41\u20139.","journal-title":"Bone"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0140-6736(89)92927-9","volume":"2","author":"JY Reginster","year":"1989","unstructured":"Reginster JY, Lecart MP, Deroisy R, Sarlet N, Denis D, Ethgen D, et al. Prevention of postmenopausal bone loss by tiludronate. Lancet 1989;2:1469\u201371.","journal-title":"Lancet"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/BF02556464","volume":"44","author":"MI Smith","year":"1989","unstructured":"Smith MI, Fogelman I, Hart DM, Scott E, Bevan J, Leggate I. Effect of etidronate disodium on bone turnover following surgical menopause. Calcif Tissue Int 1989;44:74\u20139.","journal-title":"Calcif Tissue Int"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0003-2697(67)90160-1","volume":"19","author":"KI Kivirikko","year":"1967","unstructured":"Kivirikko KI, Laitenen O, Prockop DJ. Modification of a specific assay for hydroxyproline in urine. Anal Biochem 1967;19:249\u201355.","journal-title":"Anal Biochem"},{"key":"CR22","first-page":"1507","volume-title":"Osteoporosis 1990, vol 3","author":"JP Devogelaer","year":"1990","unstructured":"Devogelaer JP, Nagant de Deuxchaisnes C. Treatment of involutional osteoporosis with the bisphosphonate APD (disodium pamidronate): non-linear increase of lumbar bone mineral density. In: Christiansen C, Overgaard K (eds) Osteoporosis 1990, vol 3. Copenhagen: Osteopress, 1990:1507\u20139."},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/jbmr.5650071207","volume":"7","author":"BC Toolan","year":"1992","unstructured":"Toolan BC, Shea M, Myers ER, Borchers RE, Seedor JG, Quartuccio H, et al. Effects of 4-amino-1-hydrobutylidene bisphosphonate on bone biomechanics in rats. J Bone Miner Res 1992,7:1399\u2013406.","journal-title":"J Bone Miner Res"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0169-6009(91)90129-N","volume":"15","author":"M Passeri","year":"1991","unstructured":"Passeri M, Baroni MC, Pedrazzoni M, Pioli G, Barbagallo M, Costi D, et al. Intermittent treatment with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosponate (AHBuBP) in the therapy of postmenopausal osteoporosis. Bone Miner 1991;15:237\u201348.","journal-title":"Bone Miner"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1210\/jcem-72-1-223","volume":"72","author":"JC Netelenbos","year":"1991","unstructured":"Netelenbos JC, Van Ginkel FC, Lips P, Barto R, Van der Wiel H, Hackeng WHL. Effect of a single infusion of aminohydroxypropylidene on calcium and bone metabolism in healthy volunteers monitored 2 months. J Clin Endocrinol Metab 1991;72:223\u20138.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01623227.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01623227\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01623227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T18:30:48Z","timestamp":1557253848000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01623227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1994,3]]}},"alternative-id":["BF01623227"],"URL":"https:\/\/doi.org\/10.1007\/bf01623227","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,3]]}}}